Sleep Disorders Trial, Recruiting NCT05350332 Sponsor: Emory University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05350332
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are willing and able to give their informed consent to participate
  • People who have been diagnosed with obstructive sleep apnea, with a breathing interruption score of 5 or more events per hour
  • People who are interested in surgical treatments for obstructive sleep apnea and have already agreed to a sleep endoscopy procedure (a camera examination done during light sedation) as part of their routine medical assessment
  • People who have been reviewed and cleared by an anaesthesia team before the procedure

Who may not be able to join:

  • People who have serious uncontrolled medical conditions, such as uncontrolled high blood pressure, unstable chest pain, poorly managed heart failure, or severe lung disease
  • People who have a medical condition that would make it unsafe for them to receive anaesthesia or undergo surgery
  • People who are unable to tolerate wearing a breathing mask device or cannot complete a breathing function test, for example due to severe claustrophobia
  • People who have a condition that significantly limits their ability to take part in the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jason Yu, MD, Emory University

Phone: 470-763-3887

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 June 2022
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Expiratory Reserve Volume (ERV); Functional Residual Capacity (FRC); Change in VOTE Collapse Patterns - Degree of Obstruction; Change in VOTE Collapse Patterns - Configuration of Obstruction; Change in Critical Closing Pressure (Pcrit); Change in Pharyngeal Opening Pressures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov